-
bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Rating of "Hold" by Analysts
Source: Buzz FX / 12 Jan 2025 04:21:16 America/New_York
bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Rating of "Hold" by Analysts Written by MarketBeat January 12, 2025 Share Link copied to clipboard. Shares of bluebird bio, Inc. ( NASDAQ:BLUE - Get Free Report ) have been assigned a consens
Read more...